Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats

Digestive Diseases and Sciences

Volumn 44, Issue 3, 1999, Pages 560-569

  Sakaida, Isao ^a   Hironaka, Koji ^a   Uchida, Koichi ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Enzyme altered lesion; Free radical; Iron; Liver fibrosis; Preneoplastic lesion

Indexed keywords

AMINO ACID; CHOLINE; DEFEROXAMINE; IRON CHELATING AGENT;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG SCREENING; LIPID PEROXIDATION; LIVER TUMOR; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; VITAMIN INTAKE;

EID: 0033025359     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026661508553     Document Type: Article

References (46)

1. 1. Starke PE, Farber JL: Ferric iron and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide. Evidence for the participation of hydroxy radicals formed by an iron-catalyzed Harber-Weiss reaction. J Biol Chem 260:10099-10104, 1985
2. 2. Sakaida I, Kyle ME, Farber JL: Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidativc stress. Mol Pharmacol 37:435-442, 1990
3. 3. Rothman RJ, Serroni A, Farber JL: Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidativc cell injury. Mol Pharmacol 42:703-710, 1992
4. 4. Kyle ME, Nakae D, Sakaida I, Miccadei S, Farber JL: Endocytosis of superoxide dismutase is required in order for the enzyme to protect hepatocytes from the cytotoxicity of hydrogen peroxide. J Biol Chem 15:3784-3789, 1988
5. 5. Sakaida I, Thomas AP, Farber JL: Increases in cytosolic calcium ion concentration can be dissociated from the killing of cultured hepatocytes by tert-butyl hydroperoxide. J Biol Chem 266:717-722, 1991
6. 6. Kyle ME, Nakae D, Sakaida I, Serroni A, Farber JL: Protein thiol depletion and the killing of cultured hepatocytes by hydrogen peroxide. Biochem Pharmacol 38:3797-3805, 1989
7. 7. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S: Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630, 1995
8. 8. Wendel A, Feuerstein S: Drug-induced lipid peroxidation in mice: I. Modulation by monooxygenase activity, glutathione and selenium status. Biochem Pharmacol 30:2513-2520, 1981
9. 9. Sakaida I, Kayano K, Wasaki S, Nagatomi A, Matsumura Y, Okita K: Protection against actaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. Scand J Gastroenterol 30:61-67, 1995
10. 10. Stal P, Johansson I, Ingelamn-Sundberg M, Hagen K, Hultcrantz R: Hepatotoxicity induced by iron overload and alcohol: Studies on the role of chelatable iron, cytochrome P4502E1 and lipid peroxidation. J Hepatol 25:538-546, 1996
11. 11. Rushmore TH, Farber E, Ghoshal AK, Pala M, Taningher M: A choline-devoid diet, carcinogenic in the rat, induces DNA damage and repair. Carcinogenesis 7:1677-1680, 1986
12. 12. Rushmore TH, Ghazarian DM, Subrahmanyan V, Farber E, Ghoshal AK: Probable free radical effects on liver nuclei early during hepatocarcinogenesis with a choline-devoid low-methionine diet. Cancer Res 47:6731-6740, 1987
13. 13. Nakae D, Yoshiji H. Mizumoto Y, Horiguchi K, Shiraiwa K, Tamura K, Denda A, Konishi Y: High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Cancer Res 52:5042-5045, 1992
14. 14. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K: The prolyl 4-hydroxylase inhibitor (HOE 077) prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 23:755-763, 1996
15. 15. Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K: Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis 15:2201-2206, 1994
16. 16. Friedman SL: The cellular basis of hepatic fibrosis. N Engl J Med 328:1828-1835, 1993
17. 17. Milani S, Herbest H, Schuppan D, Surrenti C, Riecken EO, Stein H: Cellular localization of type I, III, and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 137:59-70, 1990
18. 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis? Hepatology 19:714-721, 1994
19. 19. Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K: Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 28:298-306, 1998
20. 20. Uchida K, Sakai K, Itakura K, Osawa T, Toyokuni S: Protein modification by lipid peroxidation products: Formation of malondialdehyde derived N (epsilon)-(2-propenol) lysine in proteins. Arch Biochem Biophys 346:45-52, 1997
21. 1 expression in pig serum-induced rat liver fibrosis. J Hepatol 28:471-479, 1998
22. 22. Palinski W, Rosenfeld ME, Herttuala SY, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, et al: Low density lipoprotein undergoes modification in vivo. Proc Natl Acad Sci USA 86:1372-1376, 1989
23. 23. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216, 1976
24. 24. Stal P, Olsson J, Svoboda P, Hultcrantz R, Harma-Ringdahl M, Eriksson LC: Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis. J Hepatol 27:562-571, 1997
25. 25. Matsumura Y, Sakaida I, Uchida K, Kimura T, Ishihara T, Okita K: Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. J Hepatol 27:185-192, 1997
26. 26. Tso JY, Sun X, Kao T, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502, 1985
27. 27. Kyle ME, Sakaida I, Serroni A, Farber JL: Metabolism of acetaminophen by cultured rat hepatocytes. Biochem Pharmacol 40:1211-1218, 1990
28. 28. Ghoshal AK, Farber E: Biology of disease. Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: A new perspective. Lab Invest 68:255-260, 1993
29. 29. Sakaida I: Hepatic fibrosis and carcinogenesis. Bull Yamaguchi Med Sch 43:45-48, 1996
30. 30. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Dianzani ML: Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen gene alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 194:1044-1050, 1993
31. 31. Williams GM: The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol Pathol 17:663-674, 1989
32. 32. Kitahara A, Satoh K, Nishimura K, Ishikawa T, Koike K, Sato K, Tsuda H, Ito N: Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. Cancer Res 44:2698-2703, 1984
33. 33. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K: Purification, induction and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 82:3964-3968, 1985
34. 34. Kato T, Hasegawa R, Nakae D, Hirose M, Yaono M, Cui L, Kobayashi Y, Konishi Y, Ito N, Shirai T: Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-flquinoxaline, at low dose levels. Jpn J Can Res 87:127-133, 1996
35. 35. Coleman JB, Gilfor D, Farber JL: Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress. Mol Pharmacol 36:193-200, 1989
36. 36. Nakano M: Morphogenesis of septa in hepatic fibrosis induced by choline deficiency in rats. Acta Pathol Jpn 36:1643-1652, 1986
37. 37. Wilson MJ, Shivapurkar N, Poirier LA: Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyldeficient diet. Biochem J 218:987-990, 1984
38. 38. Wainfan E, Dizik M, Stender M, Christman JK: Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res 49:4094-4097, 1989
39. 39. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Haussinger D, Strohmeyer G: Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256-1262, 1985
40. 40. Bradbear RA, Bain C, Siskind V, Schofieid FD, Webb S, Axelsen EM, Halliday JW, Bassett ML, Powell LW: Cohort study of internal malignancy in genetic hemochromatosis and other chronic non-alcoholic liver disease. J Natl Cancer Inst 75:81-84, 1985
41. 41. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW: Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 26:584-592, 1997
42. 42. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler J: Response to Interferon a therapy is influenced by the iron content of the liver. J Hepatol 20:410-415, 1994
43. 43. Stevens R, Beasley R, Blumberg B: Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst 76:605-610, 1986
44. 44. Gordeuk VR, MacLaren CE, MacPhail AP, Deichsel G, Bothwell TH: Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 87:3470-3476, 1996
45. 45. Nelson RL, Davis FG, Shutter E, Sobin LH, Kikendall JW, Bowen P: Body iron stores and risk of colonie neoplasia. J Natl Cancer Inst 86:455-460, 1994
46. 46. Bird CL, Witte JS, Swendsied ME, Shikany LM, Hunt IF, Frankl HD, Lee ER, Longnecker MP, Haile RW: Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol 144:34-41, 1996